Villahermosa, Jusellene S.
HRN: 20-82-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2023
CEFTRIAXONE 1G (VIAL)
01/10/2023
01/17/2023
IVT
2grams
OD
T/c Urosepsis Secondary To Obstructive Uropathy From Cervical Cancer
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes